These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 36258178)

  • 1. Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs.
    Hao Z; Liang P; He C; Sha S; Yang Z; Liu Y; Shi J; Zhu Z; Chang Q
    BMC Bioinformatics; 2022 Oct; 23(1):435. PubMed ID: 36258178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
    Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
    Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To explore the prognostic characteristics of colon cancer based on tertiary lymphoid structure-related genes and reveal the characteristics of tumor microenvironment and drug prediction.
    Wang Z; Niu D
    Sci Rep; 2024 Jun; 14(1):13555. PubMed ID: 38867070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism-related lncRNAs signature to predict the prognosis of colon adenocarcinoma.
    Sun Y; Liu B; Xiao B; Jiang X; Xiang JJ; Xie J; Hu XM
    Cancer Med; 2023 Mar; 12(5):5994-6008. PubMed ID: 36366731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of long noncoding RNAs biomarkers for diagnosis and prognosis in patients with colon adenocarcinoma.
    Huang W; Liu Z; Li Y; Liu L; Mai G
    J Cell Biochem; 2019 Mar; 120(3):4121-4131. PubMed ID: 30269368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactate Metabolism-Associated lncRNA Pairs: A Prognostic Signature to Reveal the Immunological Landscape and Mediate Therapeutic Response in Patients With Colon Adenocarcinoma.
    Xiao J; Wang X; Liu Y; Liu X; Yi J; Hu J
    Front Immunol; 2022; 13():881359. PubMed ID: 35911752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
    Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
    World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures.
    Jin L; Li C; Liu T; Wang L
    Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishment of a novel ferroptosis-related lncRNA pair prognostic model in colon adenocarcinoma.
    Li H; Liu L; Huang T; Jin M; Zheng Z; Zhang H; Ye M; Liu K
    Aging (Albany NY); 2021 Oct; 13(19):23072-23095. PubMed ID: 34610581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Silico Identification and Validation of Cuproptosis-Related LncRNA Signature as a Novel Prognostic Model and Immune Function Analysis in Colon Adenocarcinoma.
    Wang Y; Huang X; Chen S; Jiang H; Rao H; Lu L; Wen F; Pei J
    Curr Oncol; 2022 Sep; 29(9):6573-6593. PubMed ID: 36135086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis.
    Liu Q; Chen N; Liu L; Zheng Q; Liao W; Zhao M; Zeng J; Tang J
    Dis Markers; 2022; 2022():4492608. PubMed ID: 36168326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and validation of a cuproptosis-related lncRNA signature as a novel and robust prognostic model for colon adenocarcinoma.
    Xu M; Mu J; Wang J; Zhou Q; Wang J
    Front Oncol; 2022; 12():961213. PubMed ID: 35965536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interferon Gamma-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Colon Adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Xie Y
    Front Oncol; 2022; 12():876660. PubMed ID: 35747790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a pyroptosis-related lncRNA risk model for predicting prognosis and immune response in colon adenocarcinoma.
    Tan Y; Lu L; Liang X; Chen Y
    World J Surg Oncol; 2022 Apr; 20(1):118. PubMed ID: 35413978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 9 Gene Signatures by WGCNA to Predict Prognosis for Colon Adenocarcinoma.
    Yang M; He H; Peng T; Lu Y; Yu J
    Comput Intell Neurosci; 2022; 2022():8598046. PubMed ID: 35392038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of lncRNA-Associated ceRNA Network Reveals Potential lncRNA Biomarkers in Human Colon Adenocarcinoma.
    Zhang Z; Qian W; Wang S; Ji D; Wang Q; Li J; Peng W; Gu J; Hu T; Ji B; Zhang Y; Wang S; Sun Y
    Cell Physiol Biochem; 2018; 49(5):1778-1791. PubMed ID: 30231249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian Clock Genes Are Correlated with Prognosis and Immune Cell Infiltration in Colon Adenocarcinoma.
    He A; Huang Z; Zhang R; Lu H; Wang J; Cao J; Feng Q
    Comput Math Methods Med; 2022; 2022():1709918. PubMed ID: 35116071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer.
    Cai HJ; Zhuang ZC; Wu Y; Zhang YY; Liu X; Zhuang JF; Yang YF; Gao Y; Chen B; Guan GX
    Bosn J Basic Med Sci; 2021 Oct; 21(5):569-576. PubMed ID: 33714257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and Validation of a Prognostic Model based on 11 E3-related Genes for Colon Cancer Patients.
    JIang W; Dong J; Zhang W; Huang Z; Guo T; Zhang K; Jiang X; Du T
    Curr Pharm Des; 2024; 30(12):935-951. PubMed ID: 38898815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer.
    Dong X; Liao P; Liu X; Yang Z; Wang Y; Zhong W; Wang B
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.